CD23: novel disease marker with a split personality

This publication has 25 references indexed in Scilit:

• Inhibition of interleukin 4‐promoted CD23 production in human B lymphocytes by transforming growth factor‐β, interferons or anti‐CD19 antibody is overriden on engaging CD40
  European Journal of Immunology, 1991
• Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases
  Clinical and Experimental Immunology, 1991
• Recombinant 25‐kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis
  European Journal of Immunology, 1991
• Synergistic effect of interleukin 1 and soluble CD23 on the growth of human CD4+ bone marrow-derived T cells
  European Journal of Immunology, 1991
• Expression of Human Recombinant CD23 in Insect Cells
  Journal of Receptor Research, 1991
• Serum levels of IgE‐binding factor (soluble CD23) in diseases associated with elevated IgE
  Clinical and Experimental Allergy, 1990
• The gene encoding CD23 leukocyte antigen (FCE2) is located on human chromosome 19
  Somatic Cell and Molecular Genetics, 1990
• Intact, 45‐kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts
  European Journal of Immunology, 1990
• Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation.
  The Journal of Experimental Medicine, 1990
• Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia
  Immunology Letters, 1989